TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.

Lv, Yinxiang

TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53. [electronic resource] - Drug design, development and therapy 2016 - 3053-3064 p. digital

Publication Type: Journal Article

1177-8881

10.2147/DDDT.S90705 doi


Antineoplastic Combined Chemotherapy Protocols--pharmacology
Carcinoma, Non-Small-Cell Lung--drug therapy
Carrier Proteins--antagonists & inhibitors
DNA-Binding Proteins--antagonists & inhibitors
Drug Resistance, Neoplasm--drug effects
Humans
Lung Neoplasms--drug therapy
Nuclear Proteins--antagonists & inhibitors
Tumor Cells, Cultured
Tumor Suppressor Protein p53--metabolism
Up-Regulation--drug effects